Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses

BACKGROUND: SARS-CoV-2 vaccination has proven the most effective measure to control the COVID-19 pandemic. Booster doses are being administered with limited knowledge on their need and effect on immunity. OBJECTIVE: To determine the duration of specific T cells, antibodies and neutralization after 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Almendro-Vázquez, Patricia, Chivite-Lacaba, Marta, Utrero-Rico, Alberto, González-Cuadrado, Cecilia, Laguna-Goya, Rocio, Moreno-Batanero, Miguel, Sánchez-Paz, Laura, Luczkowiak, Joanna, Labiod, Nuria, Folgueira, María Dolores, Delgado, Rafael, Paz-Artal, Estela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428395/
https://www.ncbi.nlm.nih.gov/pubmed/36059485
http://dx.doi.org/10.3389/fimmu.2022.981350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428395/
https://www.ncbi.nlm.nih.gov/pubmed/36059485
http://dx.doi.org/10.3389/fimmu.2022.981350

Ejemplares similares